March 28, 2024 Columns by Benjamin Hofmeister Multiple sclerosis awareness is for people with MS, too The Cambridge Dictionary defines awareness as “knowledge that something exists, or understanding of a situation or subject at the present time based on information or experience.” That definition perfectly matches the stages of my personal awareness of multiple sclerosis (MS). I don’t recall hearing much, if anything, about…
March 28, 2024 News by Lindsey Shapiro, PhD Restoring ‘lost’ pathway of neuroprotection benefits MS mice Treatment with the neuroprotective protein HB-EGF eased inflammation and promoted tissue recovery across various disease stages in a multiple sclerosis (MS) mouse model, recent research suggests. Researchers found that HB-EGF is produced by astrocytes, a type of nerve support cell, to ease acute inflammation early on, but this protective…
March 27, 2024 News by Lindsey Shapiro, PhD Eye tracking device for monitoring MS severity approved in Canada Health Canada has approved the commercial use of ETNA-MS, a software-based medical device that uses eye tracking to noninvasively measure disease severity in people with multiple sclerosis (MS). Short for Eye-Tracking Neurological Assessment for Multiple Sclerosis, ETNA-MS assesses disease severity based on a person’s eye movements. It’s intended for…
March 27, 2024 Columns by Mike Parker I had smooth sailing on my Ocrevus infusion day Where does the time go? Six months had passed since my last treatment, which meant it was time for another. After my August 2022 diagnosis of multiple sclerosis (MS), I was given only one option for treatment: Ocrevus (ocrelizumab), which is a disease-modifying therapy that’s used…